Clinical trials
Terminated Phase 2 Hepatitis B, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assembly Biosciences | 5 |
| F-star Therapeutics, Inc. | 3 |
| Antios Therapeutics, Inc | 2 |
| Arrowhead Pharmaceuticals | 2 |
| Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Altimmune, Inc. | 1 |
| Bausch Health Americas, Inc. | 1 |
| Enyo Pharma | 1 |
| Gilead Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B, Chronic | 22 |
| Hepatitis B | 8 |
| Hepatitis | 1 |
| Hepatitis D | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.